Dogwood Therapeutics, Inc.
DWTX
$4.99
-$0.07-1.38%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.81M | -10.93M | -7.73M | -2.28M | -1.05M |
| Total Depreciation and Amortization | 17.30K | 17.00K | 12.20K | -- | -- |
| Total Amortization of Deferred Charges | 0.00 | 52.40K | 58.40K | -- | -- |
| Total Other Non-Cash Items | 60.00K | 6.42M | 3.69M | 94.30K | 148.90K |
| Change in Net Operating Assets | -296.00K | -243.00K | -2.16M | 1.28M | 89.10K |
| Cash from Operations | -4.03M | -4.68M | -6.13M | -910.10K | -811.70K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 3.76M | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 3.76M | -- | -- |
| Total Debt Issued | 0.00 | 3.00M | 15.32M | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 4.37M | 0.00 | -- | 1.45M |
| Repurchase of Common Stock | -120.10K | -- | -400.00 | -70.20K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -120.10K | 7.37M | 15.32M | -70.20K | 1.45M |
| Foreign Exchange rate Adjustments | 10.10K | 1.20K | -144.60K | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.14M | 2.69M | 12.81M | -980.40K | 640.70K |